YU89903A - Derivati oksazola koji su supstituisani karboksilnom kiselinom za primenu kao ppar-alfa i -gama aktivatori u lečenju dijabetesa - Google Patents

Derivati oksazola koji su supstituisani karboksilnom kiselinom za primenu kao ppar-alfa i -gama aktivatori u lečenju dijabetesa

Info

Publication number
YU89903A
YU89903A YU89903A YUP89903A YU89903A YU 89903 A YU89903 A YU 89903A YU 89903 A YU89903 A YU 89903A YU P89903 A YUP89903 A YU P89903A YU 89903 A YU89903 A YU 89903A
Authority
YU
Yugoslavia
Prior art keywords
diabetes
treatment
gama
ppar
activators
Prior art date
Application number
YU89903A
Other languages
English (en)
Inventor
Alfred Binggeli
Markus Boehringer
Uwe Grether
Hans Hilpert
Hans-Peter Maerki
Markus Meyer
Peter Mohr
Fabienne Ricklin
Original Assignee
F.Hoffmann-La Roche Ag.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F.Hoffmann-La Roche Ag. filed Critical F.Hoffmann-La Roche Ag.
Publication of YU89903A publication Critical patent/YU89903A/sh
Publication of RS50451B publication Critical patent/RS50451B/sr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/32Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

Ovaj pronalazak se odnosi na jedinjenja formule (I) u kojoj su R1 do R7 definisani kao što je dato u opisu i zahtevima, i na njihove farmaceutski prihvatljive soli i estre. Ova jedinjenja su primenljiva za lečenje bolesti kao što je dijabetes.[The present invention relates to compounds of formula (I) wherein R1 to R7 are as defined in the description and claims, and pharmaceutically acceptable salts and esters thereof. The compounds are useful for the treatment of diseases such as diabetes.
YUP-899/03A 2001-05-10 2002-05-06 Derivati oksazola koji su supstituisani karboksilnom kiselinom za primenu kao ppar-alfa-i-gama aktivatori u lečenju dijabetesa RS50451B (sr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP01011174 2001-05-10

Publications (2)

Publication Number Publication Date
YU89903A true YU89903A (sh) 2006-03-03
RS50451B RS50451B (sr) 2010-03-02

Family

ID=47747906

Country Status (1)

Country Link
RS (1) RS50451B (sh)

Also Published As

Publication number Publication date
RS50451B (sr) 2010-03-02

Similar Documents

Publication Publication Date Title
MXPA03010435A (es) Derivados de oxazol acido carboxilico sustituidos para uso como activadores de proliferacion del peroximosa(ppar-alfa y gama) en el tratamiento de diabetes.
UA74346C2 (uk) Похідні амінодикарбонових кислот, їх застосування та лікарський засіб
SG151286A1 (en) 5-substituted-2-phenylamino-benzamide as mek inhibitor
MXPA05008172A (es) Derivados de malonamida como inhibidores gamma-secretasa.
MY143568A (en) 11b-hsd1 inhibitors for the treatment of diabetes
MY140488A (en) Substituted oxazolidinones and their use in the field of blood coagulation
NZ514234A (en) N-cyanomethylamides as protease inhibitors
MX2009006742A (es) Inhibidores acilaminopirazoles como fgfr.
GEP20094638B (en) Benzimidazolone carboxylic acid derivatives
MXPA05012415A (es) Inhibidores de glutamina fructosa-3-fosfato amidotransferasa (gfat).
MX2008014101A (es) Acidos carboxilicos sustituidos con 4,5-difenil-pirimidinilamino, metodo para su produccion y su uso como medicamentos.
TW200745097A (en) 4-Phenyl-thiazole-5-carboxylic acids and 4-phenyl-thiazole-5-carboxylic acid amides as PLK1 inhibitors
NO20050667L (no) N-substituerte-1H-indol-5-propionsyreforbindelser som PPAR agonister nyttige for behandling av diabetes
NO20051011L (no) Kirale oksazol-arylpropionsyrederivater og anvendelse derav som PPAR agonister
GEP20074045B (en) (4-phenyl) piperidin-3-yl-phenylcarboxylate derivatives and related compounds as beta-secretase inhibitors for the treatment of alzheimer's disease
ATE357453T1 (de) Comt-inhibitoren
TW200407133A (en) Novel PPARα and PPARγ agonists
MXPA05010020A (es) Derivados de oxamida.
SE0302756D0 (sv) Novel Compounds
ATE432262T1 (de) Pyrazolphenylderivate als ppar-aktivatoren
DE60107832D1 (en) Chromenylmethylpyrimidindiamine als antibakterielle wirkstoffe
YU89903A (sh) Derivati oksazola koji su supstituisani karboksilnom kiselinom za primenu kao ppar-alfa i -gama aktivatori u lečenju dijabetesa
HUP0203118A2 (hu) Béta-diszubsztituált metalloproteáz inhibitorok, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
SE0402972D0 (sv) Novel compounds
SE0201193D0 (sv) Novel use